Resources | NITAG RESOURCE CENTER

2013 ∙ Peasah, S. K. Azziz-Baumgartner, E. Breese, J. Meltzer, M. I. Widdowson, M. A.

Influenza cost and cost-effectiveness studies globally - A review

2013 ∙ Khan, A. A. Zahidie, A. Rabbani, F.

Interventions to reduce neonatal mortality from neonatal tetanus in low and middle income countries - A systematic review

2012 ∙ Bechini, A. Tiscione, E. Boccalini, S. Levi, M. Bonanni, P.

Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): A review of evidences and recommendations

2012 ∙ Makris, M. C. Polyzos, K. A. Mavros, M. N. Athanasiou, S. Rafailidis, P. I. Falagas, M. E.

Safety of hepatitis B, pneumococcal polysaccharide and meningococcal polysaccharide vaccines in pregnancy: A systematic review

2012 ∙ Brien, S. Kwong, J. C. Buckeridge, D. L.

The determinants of 2009 pandemic A/H1N1 influenza vaccination: A systematic review

2012 ∙ Thomas, R. E. Lorenzetti, D. L. Spragins, W. Jackson, D. Williamson, T.

The safety of yellow fever vaccine 17D or 17DD in children, pregnant women, HIV+ individuals, and older persons: Systematic review

2012 ∙ SAGE

Safety of inactivated influenza vaccine in pregnant women

2011 ∙ Michiels, B. Govaerts, F. Remmen, R. Vermeire, E. Coenen, S.

A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups

2011 ∙ Bish, A. Yardley, L. Nicoll, A. Michie, S.

Factors associated with uptake of vaccination against pandemic influenza: A systematic review

Conseil Supérieur des Maladies Infectieuses

Recommendations on the vaccination of pregnant women